| Trial ID: | L2134 |
| Source ID: | NCT00157482
|
| Associated Drug: |
Ezetimibe
|
| Title: |
Ezetimibe and Simvastatin in Dyslipidemia of Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Ezetimibe|DRUG: Simvastatin
|
| Outcome Measures: |
Primary: LDL-cholesterol, at 16 weeks of treatment. LDL-cholesterol is measured at -4, 0, 8, 12 and 16 weeks. | Secondary: Total cholesterol, apolipoprotein A1 and B, lipoprotein and triglycerides, at -4, 0, 8, 12 and 16 weeks|Explorative|Urinary albumin excretion, at -4, 0, 8 and 16 weeks
|
| Sponsor/Collaborators: |
Sponsor: Mario Negri Institute for Pharmacological Research
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
108
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: DIAGNOSTIC
|
| Start Date: |
2005-01
|
| Completion Date: |
2006-12
|
| Results First Posted: |
|
| Last Update Posted: |
2007-02-13
|
| Locations: |
ASl of Ponte San Pietro - Diabetologic Unit, Ponte San Pietro, Bergamo, 24036, Italy|Clinical Research Center for Rare Diseases, Ranica, Bergamo, 24020, Italy|Hospital "Treviglio Caravaggio " - Diabetologic Unit, Treviglio, Bergamo, 24047, Italy|Hospital "Ospedali Riuniti di Bergamo" - Diabetologic Unit, Bergamo, 24128, Italy
|
| URL: |
https://clinicaltrials.gov/show/NCT00157482
|
